Treatment-emergent sexual dysfunction with SSRIs and duloxetine: Effectiveness and functional outcomes over a 6-month observational period

References

• Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. J Am Med Assoc 1999;281:537–44.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Baldwin DS, Riley A. Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002;69:119–40.
   PubMed Web of Science ®Google Scholar
• Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol 2009;29:259–66.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Dickens SE, Eisfeld BS, Bagby RM. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 1999;56:201–8.
   PubMed Web of Science ®Google Scholar
• Bonierbale M, Lancon C, Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin 2003;19:114–24.
   PubMed Web of Science ®Google Scholar
• Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F . Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005;66:686–92.
   PubMed Web of Science ®Google Scholar
• Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999; 19:67–85.
   PubMed Web of Science ®Google Scholar
• Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002;36:1577–89.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 2000;61:276–81.
   PubMed Web of Science ®Google Scholar
• Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001;62(Suppl 3):10–21.
   PubMed Web of Science ®Google Scholar
• Perlis RH, Laje G, Smoller JW, Fava M, Rush AJ, McMahon FJ. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology 2009;34:1819–28.
   PubMed Web of Science ®Google Scholar
• Laje G, Perlis RH, Rush AJ, McMahon FJ. Pharmacogenetics studies in STAR*D: strengths, limitations, and results. Psychiatr Serv 2009;60:1446–57.
   PubMed Web of Science ®Google Scholar
• Zajecka JM. Clinical issues in long-term treatment with antidepressants. J Clin Psychiatry 2000;61(Suppl 2):20–5.
   PubMed Web of Science ®Google Scholar
• Montejo-Gonzalez AL, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, . SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997;23:176–94.
   PubMed Web of Science ®Google Scholar
• Derogatis LR. Sexual function and quality of life: endpoints and outcomes. J Gend Specif Med 2001;4:35–42.
   PubMedGoogle Scholar
• Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C . Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002;63: 357–66.
   PubMed Web of Science ®Google Scholar
• Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 2007; 4:917–29.
   PubMed Web of Science ®Google Scholar
• Schweitzer I, Maguire K, Ng C. Sexual side-effects of contemporary antidepressants: review. Aust NZ J Psychiatry 2009;43:795–808.
   PubMed Web of Science ®Google Scholar
• Haberfellner EM. A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials. Pharmacopsychiatry 2007;40:173–82.
   PubMed Web of Science ®Google Scholar
• Dueñas H, Lee A, Brnabic AJM, Chung KF, Lai CH, Badr MG, . Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study. Int J Psychiatry Clin Pract 2010;15:80–90.
   Web of Science ®Google Scholar
• McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, . The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000;26:25–40.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text Revision (DSM-IV-TR); 2000.
   Google Scholar
• World Health Organization (WHO). International classification of diseases (ICD-10). Arlington, VA: American Psychiatric Publishing, Inc; 1992.
   Google Scholar
• Guy W. ECDEU assessment manual for psychopharmacology – revised edition (DHEW Publ No ADM 76-338). Rockville, MD: NIMH Psychopharmacology Research Branch; 1976.
   Google Scholar
• Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, . The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54: 573–83.
   PubMed Web of Science ®Google Scholar
• Dueñas H, Tapia-Paniagua G, Vazquez-Barquero JL, Acuna A, Madrigal E, Celis A, . The integral inventory for depression (IID), a new clinimetric tool for the emotional and physically painful dimension of depression. Poster presented at the 2nd International Congress of the World Federation of Societies of Biological Psychiatry: 17–21 April 2007, Santiago, Chile.
   Google Scholar
• EuroQol group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990; 16:199–208.
   PubMed Web of Science ®Google Scholar
• Sheehan DV. The anxiety disease. New York: Charles Scribner & Sons; 1983.
   Google Scholar
• Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41–55.
   Web of Science ®Google Scholar
• D’Agostino RB Jr. Tutorial in biostatistics: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17: 2265–81.
   PubMed Web of Science ®Google Scholar
• Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 2004; 65:521–30.
   PubMed Web of Science ®Google Scholar
• Montejo AL, Prieto N, Terleira A, Matias J, Alonso S, Paniagua G, . Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale. J Psychopharmacol 2010; 24:111–20.
   PubMed Web of Science ®Google Scholar
• Thase ME, Pritchett YL, Ossanna MJ, Swindle RW, Xu J, Detke MJ. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. J Clin Psychopharmacol 2007;27:672–6.
   PubMed Web of Science ®Google Scholar
• Jain R. The implications of pain and physical symptoms in depression. J Clin Psychiatry 2009;70:e19.
   PubMedGoogle Scholar
• Chalon SA, Granier LA, Vandenhende FR, Bieck PR, Bymaster FP, Joliat MJ, . Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study. Neuropsychopharmacology 2003; 28:1685–93.
   PubMed Web of Science ®Google Scholar
• Iyengar S, Webster AA, Hemrick-Luecke SK, Xu JY, Simmons RM. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther 2004;311:576–84.
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Lu Y, Detke MJ, Hudson J, Iyengar S, Demitrack MA. Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics 2004; 45:17–28.
   PubMed Web of Science ®Google Scholar
• Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D’Souza DN. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms. Depress Anxiety 2008;25:E1–11.
   PubMed Web of Science ®Google Scholar
• Goldstein DJ. Duloxetine in the treatment of major depressive disorder. Neuropsychiatr Dis Treat 2007;3:193–209.
   PubMedGoogle Scholar
• Muñoz RA, McBride ME, Brnabic AJ, López CJ, Hetem LA, Secin R, . Major depressive disorder in Latin America: the relationship between depression severity, painful somatic symptoms, and quality of life. J Affect Disord 2005;86: 93–8.
   PubMed Web of Science ®Google Scholar
• Chen KC, Yang YK, Lee IH, Yeh TL, Lu RB, Chen PS. Sexual dysfunction and physicians’ perception in medicated patients with major depression in Taiwan. Depress Anxiety 2008;25:E56–62.
   Google Scholar
• Clayton AH, Montejo AL. Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry 2006; 67(Suppl 6):33–7.
   PubMedGoogle Scholar
• Hirschfeld RM. Management of sexual side effects of antidepressant therapy. J Clin Psychiatry 1999;60(Suppl 14):27–30.
   PubMedGoogle Scholar